Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Li Kang Biomedical Co Buyback Yield % Related Terms
Li Kang Biomedical Co Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Li Kang Biomedical Co's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6242 vs BKNG, ABNB, RCL: Buyback Yield % Comparison
For the Travel Services subindustry, Li Kang Biomedical Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Li Kang Biomedical Co Buyback Yield % vs Travel & Leisure Industry
For the Travel & Leisure industry and Consumer Cyclical sector, Li Kang Biomedical Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Li Kang Biomedical Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Li Kang Biomedical Co (ROCO:6242) has a Buyback Yield % of 0.00 as of Aug. 06, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Li Kang Biomedical Co and its competitors. According to the industry distribution chart, Li Kang Biomedical Co ranks #999999 out of 262 companies in the Travel & Leisure industry.
Is Li Kang Biomedical Co's Buyback Yield % too high?
Li Kang Biomedical Co's current Buyback Yield % is 0.00. Based on the distribution chart, Li Kang Biomedical Co ranks #999999 out of 262 companies in the Travel & Leisure industry, which is in the bottom quartile relative to peers. Overall, Li Kang Biomedical Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Li Kang Biomedical Co's Buyback Yield % compare to BKNG and ABNB?
According to the Travel & Leisure industry distribution chart, Li Kang Biomedical Co ranks #999999 out of 262 companies for Buyback Yield %. This places Li Kang Biomedical Co in the lower half of its industry. The industry median Buyback Yield % is 0.17. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Travel & Leisure company?
The median Buyback Yield % among Travel & Leisure companies is 0.17, based on 262 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Li Kang Biomedical Co and its competitors. For the Travel & Leisure industry, the median Buyback Yield % is 0.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Li Kang Biomedical Co's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Li Kang Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Li Kang Biomedical Co (ROCO:6242) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$38.71, compared to a current price of NT$35.00 — trading 9.6% below its estimated fair value. The current Buyback Yield % is 0.00. Li Kang Biomedical Co's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Li Kang Biomedical Co (ROCO:6242), the current Buyback Yield % is 0.00 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Li Kang Biomedical Co (ROCO:6242) Overvalued in 2026?
Based on GuruFocus' analysis, Li Kang Biomedical Co stock appears to be undervalued.
The current stock price of NT$35.00 is trading 9.6% below its estimated GF Value™ of NT$38.71.
GuruFocus considers Li Kang Biomedical Co to be Modestly Undervalued.
Key valuation signals for ROCO:6242:
Buyback Yield %: 0.00
GF Value™: NT$38.71 vs. price of NT$35.00 (9.6% below fair value)
No single metric tells the full story. See the ROCO:6242 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Li Kang Biomedical Co Ltd is a Taiwan based company engages in tourism factory businesses, telemarketing, as well as the manufacturing and sales of cosmetics and hygienic drinks.
81GF Score
Get the complete analysis for ROCO:6242
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6242 has been successfully added to your 
